Neoadjuvant chemotherapy with quick cisplatin-VP 16 followed by robotic radical trachelectomy in FIGO 2018 stage 1B2 cervical cancer
Background: The typical treatment of the International Federation of Gynecology and Obstetrics 2018 stage IB2 cervical cancer is radical hysterectomy. With the trend of delayed childbearing, the importance of fertility sparing in the treatment of women with cervical cancer has drawn attention. Case:...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2022-05-01
|
| Series: | Clinical and Experimental Obstetrics & Gynecology |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/CEOG/49/5/10.31083/j.ceog4905113 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Background: The typical treatment of the International Federation of Gynecology and Obstetrics 2018 stage IB2 cervical cancer is radical hysterectomy. With the trend of delayed childbearing, the importance of fertility sparing in the treatment of women with cervical cancer has drawn attention. Case: We report a case of stage IB2 cervical cancer treated by neoadjuvant chemotherapy with quick cisplatin-VP 16 followed by robotic radical trachelectomy. Conclusions: Neoadjuvant chemotherapy (NACT) using platinum-based therapy with cisplatin and trachelectomy performed through the vagina or abdominal approach was used in most previous cases. We successfully performed NACT with quick cisplatin-VP 16, followed by robotic radical trachelectomy in stage 1B2 cervical cancer. Further studies are needed to accumulate cases and outcomes of fertility-preserving treatment techniques. |
|---|---|
| ISSN: | 0390-6663 |